Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ · Healthcare
Ionis Pharmaceuticals, Inc. Long Term Debt 2008–2025
Ionis Pharmaceuticals, Inc. annual long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Ionis Pharmaceuticals, Inc. long term debt as of December 31, 2025: 1.81B, a 44.64% increase year-over-year.
- Ionis Pharmaceuticals, Inc. long term debt for 2025 were 1.81B, a 44.64% increase from 2024.
- Ionis Pharmaceuticals, Inc. long term debt for 2024 were 1.25B, a 4.23% decrease from 2023.
- Ionis Pharmaceuticals, Inc. long term debt for 2023 were 1.31B, a 9.56% increase from 2022.
- Ionis Pharmaceuticals, Inc. long term debt for 2022 were 1.19B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ionis Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $1,812 |
| 2024 | $1,253 |
| 2023 | $1,308 |
| 2022 | $1,194 |
Ionis Pharmaceuticals, Inc. Long Term Debt — FAQ
Ionis Pharmaceuticals, Inc. (IONS) long term debt over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IONS's long term debt history?
The chart and table above show Ionis Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.